PM360

DECEMBER 20, 2023

Furthermore, the Chinese government maintains its support for local manufacturers to bridge the gap left by innovative foreign drugs or to substitute them with more cost-effective local alternatives. Regulatory body – NMPA : all pharmaceutical products sold in the Chinese market need to be granted market authorization by NMPA.

Marketing 105

Marketing Insurance Medical Manufacturing 105

pharmaphorum

NOVEMBER 25, 2022

The Parma site, as yet only nine months into construction, is due to become operational from 2024, with FDA, IFA, and EMA approvals due to be sought for 2025. Going beyond the standards of care; improving drug safety and efficacy. But to make people safe requires a lot of research.

Pharmaceutical 96

Pharmaceutical Manufacturing Medicine Competition 96

PM360

AUGUST 9, 2022

Driven by predictive analytics and machine learning, ACT ICS PRM allows manufacturers to rapidly identify patient behaviors and patterns to develop personas and predict the “next best action” for personalized engagement. Pharma Manufacturer Solutions. GM of Manufacturer Solutions. Aaron Crittenden. acrittenden@goodrx.com.

Prescription 105

Prescription Medical Side effects Patients 105

European Pharmaceutical Review

JULY 3, 2023

The Office of Pharmaceutical Quality (OPQ) in the US Food and Drug Administration (FDA)’s Center Pharmaceutical Quality for Drug Evaluation and Research (CDER) has released its 2022 annual report analysing drug manufacturers and their products. FDA’s sampling and testing programme found 892 of 1,552 product samples (57.5

FDA 87

FDA Food and Drug Administration Manufacturing Product sample 87

Pharmaceutical Technology

AUGUST 30, 2022

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

Manufacturing 78

Manufacturing Marketing Pharma Distribution 78

pharmaphorum

OCTOBER 26, 2022

The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We We promptly discussed this need with the FDA and the agency agreed to a proposed amendment of the protocol to accommodate, in a safe manner, the patient access to the EAP.”.

Patients 81

Patients Pharma Consulting Transportation 81

World of DTC Marketing

DECEMBER 10, 2020

However, because of manufacturer discounts and rebates, the extent to which increases in wholesale list prices are associated with amounts paid by patients and insurers is poorly characterized. years to win FDA approval, at a median cost of $648 million. Drug wholesale list prices have doubled in recent years.

Insurance 181

Insurance Pharma Manufacturing Retail 181

PM360

APRIL 25, 2023

biosimilars market to date, the first of eight FDA-approved Humira (adalimumab) biosimilars launched in the United States in January after years of regulatory delays. In perhaps the most significant moment for the U.S. 2022 was a fascinating year for biosimilars, but may prove dull to 2023.

Marketing 97

Marketing Competition Government Manufacturing 97

European Pharmaceutical Review

AUGUST 9, 2022

Burkholderia species are one of the primary causes of non-sterile pharmaceutical product recalls and accounted for 45.3 percent of recalls recorded by the US Food and Drug Administration (FDA) between 2012 and 2019. Daddy Gaoh et al.

Food and Drug Administration 81

Food and Drug Administration Pharmaceutical products Pharmaceutical Pharmaceutical manufacturing 81

Pharmaceutical Technology

MAY 11, 2008

” LEVEL TRACKING Pharmaceutical manufacturing company Seidenader Vision has also developed a system – the SATrack and Trace. ” THE DOMINO EFFECT There are many examples of how these technologies have helped make pharmaceutical manufacturing safer for the consumer.

Electronics 52

Electronics Transportation Pharmaceutical manufacturing Pharmaceutical 52